Search - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS Access content directly

Filter your results

12 Results
authFullName_s : Mauricette Michallet

Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.

Jean-Luc Harousseau , Herve Avet-Loiseau , Michel Attal , Catherine Charbonnel , Frederic Garban , et al.
Journal of Clinical Oncology, 2009, 27 (34), pp.5720-6. ⟨10.1200/JCO.2008.21.1060⟩
Journal articles hal-00821143v1

Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Claire Fabre , Serge Koscielny , Mohamad Mohty , Nathalie Fegueux , Didier Blaise , et al.
Haematologica, 2012, 97 (4), pp.482-90. ⟨10.3324/haematol.2011.049742⟩
Journal articles hal-00849621v1

Double umbilical cord blood transplantation for hematological malignancies: a long- term analysis from the SFGM-TC registry.

Hélène Labussière Wallet , Mohamad Sobh , Stéphane Morisset , Marie Robin , Nathalie Fegueux , et al.
Experimental Hematology, 2013, 41 (11), pp.924-933. ⟨10.1016/j.exphem.2013.05.297⟩
Journal articles hal-00849674v1

Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma.

Philippe Moreau , Frédéric Garban , Michel Attal , Mauricette Michallet , Gérald Marit , et al.
Blood, 2008, 112 (9), pp.3914-5. ⟨10.1182/blood-2008-07-168823⟩
Journal articles hal-00821148v1
Image document

Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.

Gandhi Damaj , Alain Duhamel , Marie Robin , Yves Beguin , Mauricette Michallet , et al.
Journal of Clinical Oncology, 2012, 30 (36), pp.4533-40. ⟨10.1200/JCO.2012.44.3499⟩
Journal articles inserm-00821506v1

Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Mauricette Michallet , Quoc-Hung Le , Mohamad Mohty , Thomas Prébet , Franck Nicolini , et al.
Experimental Hematology, 2008, 36 (5), pp.535-44. ⟨10.1016/j.exphem.2008.01.017⟩
Journal articles inserm-00484237v1

Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Marie Robin , Reza Tabrizi , Mohamad Mohty , Sabine Furst , Mauricette Michallet , et al.
British Journal of Haematology, 2011, 152 (3), pp.331-9. ⟨10.1111/j.1365-2141.2010.08417.x⟩
Journal articles hal-00849650v1
Image document

Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial

Didier Blaise , Raynier Devillier , Anne-Gaelle Lecoroller-Sorriano , Jean-Marie Boher , Agnès Boyer-Chammard , et al.
Haematologica, 2015, 100 (2), pp.269-274. ⟨10.3324/haematol.2014.113571⟩
Journal articles hal-02167058v1

Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC.

Patrice Chevallier , Richard M Szydlo , Didier Blaise , Reza Tabrizi , Mauricette Michallet , et al.
Biology of Blood and Marrow Transplantation, 2012, 18 (2), pp.289-94. ⟨10.1016/j.bbmt.2011.07.013⟩
Journal articles hal-00849660v1

Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.

Patrice Chevallier , Mohamad Mohty , Bruno Lioure , Gérard Michel , Nathalie Contentin , et al.
Journal of Clinical Oncology, 2008, 26 (30), pp.4940-3. ⟨10.1200/JCO.2007.15.6315⟩
Journal articles inserm-00484234v1

Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02

Xavier Leleu , Michel Attal , Bertrand Arnulf , Philippe Moreau , Catherine Traulle , et al.
Blood, 2013, 121 (11), pp.1968--1975. ⟨10.1182/blood-2012-09-452375⟩
Journal articles hal-01064417v1

Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.

Michel Attal , Valerie Lauwers-Cances , Gerald Marit , Denis Caillot , Philippe Moreau , et al.
New England Journal of Medicine, 2012, 366 (19), pp.1782-91. ⟨10.1056/NEJMoa1114138⟩
Journal articles hal-00852275v1